— Know what they know.
/
Not Investment Advice

ZVRA NASDAQ

Zevra Therapeutics, Inc.
1W: -10.0% 1M: +0.0% 3M: +19.2% YTD: +25.8% 1Y: +21.8% 3Y: +124.6% 5Y: +15.2%
$10.03
-0.46 (-4.39%)
 
Weekly Expected Move ±7.5%
$9 $10 $11 $12 $13
NASDAQ · Healthcare · Biotechnology · Alpha Radar Neutral · Power 51 · $592.9M mcap · 55M float · 2.25% daily turnover · Short 55% of daily vol
Overview News Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings
Dividends Analysis Technicals Weather Peers ESG Institutions ETF Exposure Dark Pool Short Interest Supply Chain

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
52.8 / 100
NoneWeakNarrowWide
Primary source: Network Effects  ·  ROIC: -169.1%  ·  5Y Avg: 24.6%
Cost Advantage
54
Intangibles
55
Switching Cost
53
Network Effect
78
Scale
22
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. ZVRA shows a Weak competitive edge (52.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Network Effects. Negative ROIC of -169.1% indicates the company is currently destroying value, though this may reflect a growth investment phase.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$25
Low
$25
Avg Target
$25
High
Based on 1 analyst since May 6, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 8Hold: 0Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$24.00
Analysts2
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-08 Guggenheim Eddie Hickman $23 $25 +2 +127.3% $11.00
2026-03-10 Guggenheim Eddie Hickman $22 $23 +1 +108.5% $11.03
2025-12-30 H.C. Wainwright Brandon Folkes $20 $26 +6 +194.8% $8.82
2025-11-06 Cantor Fitzgerald Kristen Kluska Initiated $24 — +158.5% $9.29
2025-11-06 Canaccord Genuity — $22 $24 +2 +168.2% $8.95
2025-03-13 Guggenheim — $21 $22 +1 +177.1% $7.94
2025-03-12 JMP Securities — $17 $18 +1 +127.3% $7.92
2025-02-04 Guggenheim Zevra Therapeutics to $ Initiated $21 — +158.3% $8.13
2024-09-24 Roth Capital Jonathan Aschoff Initiated $21 — +177.0% $7.58
2024-09-24 Maxim Group Jason McCarthy Initiated $25 — +229.8% $7.58
2024-09-23 JMP Securities Jason Butler Initiated $17 — +124.3% $7.58
2024-09-23 H.C. Wainwright Oren Livnat Initiated $20 — +152.5% $7.92
2024-09-18 Canaccord Genuity Sumant Kulkarni Initiated $22 — +192.2% $7.53

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

A-
May 22, 2026
DCF
1
ROE
5
ROA
5
D/E
4
P/E
3
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. ZVRA receives an overall rating of A-. Strongest factors: ROE (5/5), ROA (5/5), D/E (4/5). Areas of concern: DCF (1/5).
Rating Change History
DateFromTo
2026-05-11 A A-
2026-05-07 C- A
2026-05-06 B+ C-
2026-04-24 B B+
2026-04-01 B+ B
2026-01-16 C+ B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

★ ★ ★ ★ ★ 62 Grade B
Profitability
95
Balance Sheet
89
Earnings Quality
9
Growth
91
Value
76
Momentum
63
Safety
65
Cash Flow
36
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. ZVRA scores highest in Profitability (95/100) and lowest in Earnings Quality (9/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
2.92
Grey Zone
Piotroski F-Score
7/9
✓ ✓ ✓ ✗ ✓ ✓ ✗ ✓ ✓
Beneish M-Score
0.22
Possible Manipulator
Ohlson O-Score
-9.13
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
AA-
Score: 84.2/100
Trend: Improving
Earnings Quality
25/100
OCF/NI: 0.10x
Accruals: 48.2%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. ZVRA scores 2.92, placing it in the Grey Zone (safe > 2.99, distress < 1.81). Financial distress is possible and warrants monitoring. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. ZVRA scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. ZVRA's score of 0.22 exceeds the −1.78 red flag threshold — this does not confirm manipulation but indicates the earnings profile resembles past manipulators statistically. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. ZVRA's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. ZVRA receives an estimated rating of AA- (score: 84.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). ZVRA's score of 25/100 is low — reported earnings may not be fully supported by cash flows.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
4.72x
PEG
0.00x
P/S
4.85x
P/B
2.85x
P/FCF
46.80x
P/OCF
43.97x
EV/EBITDA
4.08x
EV/Revenue
3.55x
EV/EBIT
4.19x
EV/FCF
36.14x
Earnings Yield
22.13%
FCF Yield
2.14%
Shareholder Yield
0.00%
Graham Number
$10.92
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 4.7x earnings, ZVRA trades at a deep value multiple. An earnings yield of 22.1% exceeds typical risk-free rates, suggesting equities are being compensated for risk. Graham's intrinsic value formula yields $10.92 per share, suggesting a potential 9% margin of safety at the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.931
NI / EBT
×
Interest Burden
1.290
EBT / EBIT
×
EBIT Margin
0.846
EBIT / Rev
×
Asset Turnover
0.528
Rev / Assets
×
Equity Multiplier
2.382
Assets / Equity
=
ROE
127.8%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. ZVRA's ROE of 127.8% is driven by EBIT Margin (0.846) as the dominant factor. A tax burden ratio of 0.93 indicates minimal tax leakage — the company retains over 90% of pre-tax earnings.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.00%
Fair P/E
8.50x
Intrinsic Value
$17.53
Price/Value
0.53x
Margin of Safety
46.83%
Premium
-46.83%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with ZVRA's realized 0.0% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $17.53, ZVRA appears undervalued with a 47% margin of safety. The adjusted fair P/E of 8.5x compares to the current market P/E of 4.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$10.03
Median 1Y
$6.07
5th Pctile
$1.62
95th Pctile
$22.80
Ann. Volatility
85.3%
Analyst Target
$24.00
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
R. LaDuane Clifton
, MBA, CPA Former Chief Financial Officer and Treasurer
 $477,307 $1,260,373 $3,821,924
Neil F. McFarlane
President, Chief Executive Officer and Director
 $729,167 $874,125 $3,782,042
Rahsaan W. Thompson
Chief Legal Officer, Secretary and Compliance Officer
 $466,667 $272,680 $1,571,374

CEO Pay Ratio

97:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $3,782,042
Avg Employee Cost (SGA/emp): $38,808
Employees: 2,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
2,000
+3289.8% YoY
Revenue / Employee
$53,235
Rev: $106,470,000
Profit / Employee
$41,615
NI: $83,229,000
SGA / Employee
$38,808
Avg labor cost proxy
R&D / Employee
$6,372
Innovation spend

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 17.0% 15.2% -28.2% -0.4% -1.0% -1.2% -41.1% -52.3% -31.1% -34.8% -60.3% -65.3% -90.6% -1.2% -2.1% -1.8% 5.2% 69.6% 85.7% 1.3% 1.28%
ROA -1.1% -98.6% -11.9% -0.2% -42.1% -48.9% -33.5% -42.6% -25.3% -28.3% -28.7% -31.1% -43.2% -59.0% -60.2% -52.5% 1.5% 20.2% 36.0% 53.7% 53.67%
ROIC -84.7% -74.5% 37.3% -5.3% -1.5% -1.7% -3.0% -3.8% -2.5% -3.1% -1.0% -1.2% -1.5% -1.8% -2.3% -1.9% -48.3% -1.9% -2.3% -1.7% -1.69%
ROCE -2.3% -2.4% -6.3% -0.0% -24.1% -27.8% -40.8% -51.7% -30.1% -36.9% -44.4% -47.2% -62.7% -80.4% -57.5% -46.4% 20.7% 42.9% 38.6% 42.1% 42.14%
Gross Margin 91.7% 1.0% 97.7% 99.8% 96.1% 95.1% 93.8% 96.1% 92.0% 95.0% 78.9% 4.7% 19.7% 37.7% 88.7% 93.4% 52.2% 94.0% 95.5% 93.7% 93.75%
Operating Margin 48.7% -1.1% -1.1% -46.9% -19.1% -2.3% -4.0% -4.0% -73.8% -5.3% -1.1% -6.0% -5.3% -7.4% -1.3% -26.3% -2.7% 15.9% 27.3% 24.4% 24.38%
Net Margin 51.8% -89.5% -1.0% -47.0% -18.5% -2.3% -3.9% -4.2% -30.4% -3.6% -1.1% -4.9% -4.5% -9.0% -3.0% -15.2% 2.9% -2.1% 35.6% 1.0% 1.05%
EBITDA Margin 52.5% -85.9% -1.0% -45.3% -18.9% -2.1% -3.8% -4.1% -28.0% -4.6% -1.1% -4.2% -3.6% -7.9% -1.4% 8.3% 3.1% 5.6% 43.9% 25.4% 25.40%
FCF Margin 41.6% 35.6% 36.1% 46.0% -1.2% -1.4% -1.8% -2.0% -1.4% -1.3% -1.2% -1.6% -2.3% -2.8% -3.0% -1.5% -75.0% -28.7% -2.3% 9.8% 9.81%
OCF Margin 41.9% 36.0% 36.4% 46.5% -1.1% -1.4% -1.8% -2.0% -1.4% -1.3% -1.2% -1.6% -2.3% -2.8% -3.0% -1.5% -74.5% -27.7% -1.5% 10.4% 10.44%
ROE 3Y Avg snapshot only -74.62%
ROE 5Y Avg snapshot only -58.88%
ROA 3Y Avg snapshot only -11.32%
ROIC Economic snapshot only -21.07%
Cash ROA snapshot only 4.48%
Cash ROIC snapshot only 47.54%
CROIC snapshot only 44.67%
NOPAT Margin snapshot only -37.12%
Pretax Margin snapshot only 1.09%
R&D / Revenue snapshot only 11.35%
SGA / Revenue snapshot only 64.48%
SBC / Revenue snapshot only 7.78%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio -31.28 -30.69 -35.99 -1411.12 -5.06 -6.11 -3.81 -3.58 -5.50 -4.76 -6.01 -5.42 -3.31 -3.91 -4.24 -4.40 187.68 15.06 6.16 4.52 4.716
P/S Ratio 13.17 11.56 10.75 8.47 15.66 20.08 15.15 19.61 10.27 9.93 8.94 8.65 8.56 13.39 18.96 9.98 8.00 6.31 4.82 4.59 4.849
P/B Ratio -5.63 -4.95 2.42 1.37 1.21 1.69 2.11 2.52 2.30 2.23 4.01 3.92 3.32 5.36 11.28 10.21 12.51 13.41 3.32 3.63 2.846
P/FCF 31.70 32.48 29.79 18.42 -13.61 -14.18 -8.42 -9.78 -7.23 -7.57 -7.34 -5.28 -3.65 -4.76 -6.43 -6.55 -10.67 -21.96 -210.88 46.80 46.799
P/OCF 31.41 32.13 29.50 18.19 — — — — — — — — — — — — — — — 43.97 43.972
EV/EBITDA -55.02 -46.70 -25.03 305.01 -1.40 -2.98 -2.29 -2.39 -3.59 -2.75 -5.25 -4.95 -3.13 -4.17 -5.74 -6.57 13.36 7.78 3.90 4.08 4.082
EV/Revenue 15.51 13.89 6.88 3.07 4.37 9.75 9.02 12.98 6.46 6.13 8.08 7.80 7.56 12.42 18.57 9.76 7.85 6.20 3.62 3.55 3.545
EV/EBIT -53.28 -45.31 -24.23 -1208.29 -1.38 -2.92 -2.24 -2.35 -3.49 -2.71 -5.12 -4.69 -2.93 -3.88 -5.30 -5.93 16.30 8.45 4.07 4.19 4.191
EV/FCF 37.32 39.04 19.07 6.67 -3.80 -6.89 -5.02 -6.47 -4.55 -4.68 -6.63 -4.75 -3.22 -4.42 -6.29 -6.41 -10.47 -21.58 -158.35 36.14 36.144
Earnings Yield -3.2% -3.3% -2.8% -0.1% -19.8% -16.4% -26.2% -27.9% -18.2% -21.0% -16.6% -18.5% -30.2% -25.6% -23.6% -22.7% 0.5% 6.6% 16.2% 22.1% 22.13%
FCF Yield 3.2% 3.1% 3.4% 5.4% -7.3% -7.1% -11.9% -10.2% -13.8% -13.2% -13.6% -19.0% -27.4% -21.0% -15.6% -15.3% -9.4% -4.6% -0.5% 2.1% 2.14%
PEG Ratio snapshot only 0.001
Price/Tangible Book snapshot only 3.911
EV/OCF snapshot only 33.961
EV/Gross Profit snapshot only 4.146
Shareholder Yield snapshot only 0.00%
Graham Number snapshot only $10.92
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.11 1.11 27.20 27.20 27.20 27.20 7.72 7.72 7.72 7.72 1.18 1.18 1.18 1.18 2.53 2.53 2.53 2.53 5.68 5.68 5.678
Quick Ratio 1.11 1.11 27.20 27.20 27.20 27.20 7.72 7.72 7.72 7.72 0.85 0.85 0.85 0.85 2.47 2.47 2.47 2.47 5.63 5.63 5.634
Debt/Equity -1.06 -1.06 0.01 0.01 0.01 0.01 0.25 0.25 0.25 0.25 0.71 0.71 0.71 0.71 1.52 1.52 1.52 1.52 0.41 0.41 0.409
Net Debt/Equity — — -0.87 -0.87 -0.87 -0.87 -0.85 -0.85 -0.85 -0.85 -0.39 -0.39 -0.39 -0.39 -0.23 -0.23 -0.23 -0.23 -0.83 -0.83 -0.826
Debt/Assets 6.29 6.29 0.01 0.01 0.01 0.01 0.16 0.16 0.16 0.16 0.25 0.25 0.25 0.25 0.34 0.34 0.34 0.34 0.22 0.22 0.222
Debt/EBITDA -8.81 -8.34 -0.20 7.81 -0.05 -0.05 -0.46 -0.36 -0.62 -0.50 -1.02 -0.99 -0.76 -0.59 -0.79 -1.00 1.65 0.90 0.64 0.60 0.595
Net Debt/EBITDA -8.29 -7.84 14.05 -537.56 3.62 3.16 1.55 1.22 2.11 1.70 0.56 0.54 0.41 0.33 0.12 0.15 -0.25 -0.14 -1.29 -1.20 -1.203
Interest Coverage -2.22 -4.38 -21.13 -1.27 -596.17 -210.43 -125.81 -104.34 -46.29 -41.67 -29.15 -22.68 -15.60 -13.41 -11.26 -7.78 3.52 7.52 11.87 24.07 24.071
Equity Multiplier -0.17 -0.17 1.05 1.05 1.05 1.05 1.54 1.54 1.54 1.54 2.79 2.79 2.79 2.79 4.49 4.49 4.49 4.49 1.84 1.84 1.841
Cash Ratio snapshot only 4.863
Debt Service Coverage snapshot only 24.717
Cash to Debt snapshot only 3.022
FCF to Debt snapshot only 0.190
Defensive Interval snapshot only 509.9 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 2.62 2.62 0.40 0.28 0.14 0.15 0.08 0.08 0.14 0.14 0.19 0.19 0.17 0.17 0.13 0.23 0.35 0.48 0.46 0.53 0.528
Inventory Turnover — — — — — — — — — — 0.31 0.57 0.81 0.99 0.81 0.66 1.34 1.28 9.05 9.55 9.551
Receivables Turnover 13.77 13.79 14.83 10.61 5.08 5.55 2.43 2.25 3.91 3.92 2.38 2.40 2.06 2.13 1.80 3.09 4.72 6.42 6.48 7.45 7.448
Payables Turnover 1.73 1.73 2.44 1.26 0.14 0.31 0.17 0.22 0.53 0.53 0.42 0.78 1.11 1.36 0.78 0.63 1.29 1.23 2.16 2.28 2.278
DSO 27 26 25 34 72 66 150 162 93 93 153 152 177 172 203 118 77 57 56 49 49.0 days
DIO 0 0 0 0 0 0 0 0 0 0 1178 640 450 368 453 554 273 286 40 38 38.2 days
DPO 211 211 150 289 2614 1191 2196 1637 694 692 861 467 329 269 470 575 284 297 169 160 160.2 days
Cash Conversion Cycle -185 -185 -125 -255 -2542 -1125 -2046 -1475 -600 -598 470 324 298 271 186 97 67 46 -72 -73 -73.0 days
Fixed Asset Turnover snapshot only 71.892
Operating Cycle snapshot only 87.2 days
Cash Velocity snapshot only 0.640
Capital Intensity snapshot only 2.328
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 30.0% 1.3% 1.2% -12.1% -65.4% -62.3% -63.5% -52.8% 71.6% 57.3% 1.7% 1.9% 42.4% 47.0% -14.9% 44.9% 1.6% 2.4% 3.5% 2.0% 2.01%
Net Income -45.5% 23.2% 33.0% 99.3% -1.5% -2.3% -3.9% -429.0% -3.5% 0.1% 0.6% 15.5% -97.5% -1.4% -1.6% -1.1% 1.0% 1.4% 1.8% 2.4% 2.35%
EPS 80.3% 90.3% 91.4% 99.6% -1.2% -2.4% -4.0% -429.5% -5.2% 0.8% 9.5% 30.3% -59.8% -75.3% -80.4% -58.9% 1.0% 1.4% 1.7% 2.2% 2.21%
FCF 3.3% 3.5% 6.2% 4.7% -2.0% -2.5% -2.8% -3.1% -1.1% -45.6% -79.9% -1.4% -1.4% -2.2% -1.1% -34.6% 17.4% 65.2% 96.5% 1.2% 1.19%
EBITDA -3.6% -34.9% -47.5% 1.0% -2.8% -3.1% -4.2% -255.7% 1.1% -7.3% -3.8% 16.0% -91.1% -96.1% -78.7% -36.8% 1.6% 1.9% 2.3% 2.8% 2.76%
Op. Income 4.5% 2.1% 2.4% -1.2% -4.8% -5.9% -6.5% -48.1% -10.3% -21.1% -15.6% -6.2% -1.1% -97.4% -77.1% -26.6% -60.3% -1.6% 27.7% 32.2% 32.18%
OCF Growth snapshot only 1.21%
Asset Growth snapshot only 59.85%
Equity Growth snapshot only 2.90%
Debt Growth snapshot only 4.83%
Shares Change snapshot only 11.34%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y — — — — — -2.2% -6.6% -13.5% -8.3% 11.1% 27.8% 6.3% -5.5% -4.5% -6.2% 25.6% 84.9% 98.9% 1.2% 1.3% 1.33%
Revenue 5Y — — — — — — — — — — — — — 16.7% 13.0% 22.1% 23.2% 47.0% 51.6% 39.3% 39.30%
EPS 3Y — — — — — — — — — — — — — — — — — — — — —
EPS 5Y — — — — — — — — — — — — — — — — — — — — —
Net Income 3Y — — — — — — — — — — — — — — — — — — — — —
Net Income 5Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 3Y — — — — — — — — — — — — — — — — — — — — —
EBITDA 5Y — — — — — — — — — — — — — — — — — — — — —
Gross Profit 3Y — — — — — -0.0% 0.7% -6.6% -3.6% 20.3% 26.1% -0.8% -18.6% -21.4% -21.0% 18.1% 66.4% 86.4% 1.1% 1.2% 1.25%
Gross Profit 5Y — — — — — — — — — — — — — 4.2% 5.8% 23.1% 20.5% 49.6% 49.6% 37.0% 36.99%
Op. Income 3Y — — — — — — — — — — — — — — — — — — — — —
Op. Income 5Y — — — — — — — — — — — — — — — — — — — — —
FCF 3Y — — — — — — — — — — — — — — — — — — — — —
FCF 5Y — — — — — — — — — — — — — — — — — — — — —
OCF 3Y — — — — — — — — — — — — — — — — — — — — —
OCF 5Y — — — — — — — — — — — — — — — — — — — — —
Assets 3Y -40.2% -40.2% 70.7% 70.7% 70.7% 70.7% 1.2% 1.2% 1.2% 1.2% 1.5% 1.5% 1.5% 1.5% 10.2% 10.2% 10.2% 10.2% 35.2% 35.2% 35.15%
Assets 5Y -27.4% -27.4% 9.4% 9.4% 9.4% 9.4% 17.1% 17.1% 17.1% 17.1% 45.2% 45.2% 45.2% 45.2% 76.1% 76.1% 76.1% 76.1% 91.0% 91.0% 90.97%
Equity 3Y — — — — — — — — — — — — — — -32.2% -32.2% -32.2% -32.2% 27.2% 27.2% 27.21%
Book Value 3Y — — — — — — — — — — — — — — -41.0% -41.6% -42.4% -42.3% 7.5% 5.6% 5.62%
Dividend 3Y — — — — — — — — — — — — — — — — — — — — —
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.68 0.78 0.80 0.79 0.37 0.42 0.40 0.29 0.19 0.33 0.54 0.45 0.36 0.13 0.19 0.51 0.40 0.54 0.53 0.53 0.529
Earnings Stability 0.10 0.15 0.21 0.56 0.41 0.26 0.18 0.10 0.21 0.09 0.01 0.06 0.26 0.61 0.62 0.67 0.05 0.00 0.03 0.10 0.099
Margin Stability — 0.88 0.90 0.88 0.90 0.88 0.90 0.90 0.92 0.88 0.95 0.89 0.79 0.78 0.80 0.88 0.80 0.77 0.81 0.90 0.900
Rev. Growth Consistency 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 0.00 1.00 1.00 1.00 0.50 1.00 1.000
Earn. Growth Consistency 0.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 0.500
FCF Positive Streak 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Earnings Persistence 0.82 0.91 0.87 0.50 0.50 0.50 0.50 0.50 0.99 1.00 1.00 0.94 0.50 0.50 0.50 0.50 0.20 0.20 0.20 0.20 0.200
Earnings Smoothness — — — — — — — — — — — — — — — — — — — — —
ROE Trend — — — — — — — — — — -0.36 -0.37 -0.67 -1.00 -2.05 -1.61 0.78 1.81 2.20 2.32 2.324
Gross Margin Trend — 0.11 0.09 0.10 0.12 0.14 0.05 0.01 -0.02 -0.02 -0.08 -0.20 -0.37 -0.44 -0.36 -0.07 -0.04 0.08 0.13 0.08 0.084
FCF Margin Trend — 2.07 1.36 1.01 -1.24 -1.43 -1.90 -2.18 -1.05 -0.78 -0.50 -0.87 -1.06 -1.45 -1.44 0.30 1.13 1.77 2.06 1.68 1.679
Sustainable Growth Rate — — — — — — — — — — — — — — — — 5.2% 69.6% 85.7% 1.3% 1.28%
Internal Growth Rate — — — — — — — — — — — — — — — — 1.5% 25.2% 56.2% 1.2% 1.16%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income -1.00 -0.96 -1.22 -77.56 0.37 0.43 0.45 0.36 0.76 0.62 0.81 1.02 0.90 0.82 0.66 0.67 -17.48 -0.66 -0.02 0.10 0.103
FCF/OCF 0.99 0.99 0.99 0.99 1.00 1.01 1.00 1.01 1.00 1.01 1.01 1.01 1.00 1.00 1.00 1.00 1.01 1.04 1.52 0.94 0.940
FCF/Net Income snapshot only 0.097
OCF/EBITDA snapshot only 0.120
CapEx/Revenue 0.4% 0.4% 0.4% 0.6% 0.5% 0.7% 0.9% 1.1% 0.7% 1.5% 1.1% 1.0% 1.0% 0.3% 0.0% 0.2% 0.5% 1.0% 0.8% 0.6% 0.63%
CapEx/Depreciation snapshot only 0.278
Accruals Ratio -2.20 -1.93 -0.26 -0.13 -0.27 -0.28 -0.18 -0.27 -0.06 -0.11 -0.05 0.01 -0.04 -0.11 -0.20 -0.17 0.28 0.33 0.37 0.48 0.482
Sloan Accruals snapshot only 0.557
Cash Flow Adequacy snapshot only 16.558
Earnings Quality Score snapshot only 0.250
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Payout Ratio — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% — — — — — — — — — — — — — — — 0.0% 0.00%
Total Payout Ratio — — — — — — — — — — — — — — — — 0.0% 0.0% 0.0% 0.0% 0.00%
Div. Increase Streak — — — — — — — — — — — — — — — — — — — — —
Chowder Number — — — — — — — — — — — — — — — — — — — — —
Buyback Yield 0.0% 0.0% 0.9% 4.3% 4.9% 3.5% 3.0% 1.8% 2.0% 2.1% 1.4% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.00%
Net Buyback Yield -14.3% -16.5% -16.7% 1.5% 4.3% 3.5% 2.8% 1.6% 1.8% 1.8% -1.2% -3.1% -3.6% -21.7% 0.0% -0.2% -0.4% -10.5% -2.4% -3.6% -3.63%
Total Shareholder Return -14.3% -16.5% -16.7% 1.5% 4.3% 3.5% 2.8% 1.6% 1.8% 1.8% -1.2% -3.1% -3.6% -21.7% 0.0% -0.2% -0.4% -10.5% -2.4% -3.6% -3.63%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 1.00 1.00 1.00 1.32 0.98 0.98 0.98 0.98 0.99 1.00 1.00 1.00 1.00 1.00 1.17 1.22 0.12 0.66 0.96 0.93 0.931
Interest Burden (EBT/EBIT) 1.45 1.23 1.05 1.79 1.00 1.00 1.00 1.01 1.02 0.92 0.94 0.96 1.00 1.07 1.09 1.13 0.72 0.87 0.92 1.29 1.290
EBIT Margin -0.29 -0.31 -0.28 -0.00 -3.16 -3.34 -4.03 -5.52 -1.85 -2.26 -1.58 -1.66 -2.58 -3.20 -3.51 -1.65 0.48 0.73 0.89 0.85 0.846
Asset Turnover 2.62 2.62 0.40 0.28 0.14 0.15 0.08 0.08 0.14 0.14 0.19 0.19 0.17 0.17 0.13 0.23 0.35 0.48 0.46 0.53 0.528
Equity Multiplier -0.15 -0.15 2.37 2.37 2.37 2.37 1.23 1.23 1.23 1.23 2.10 2.10 2.10 2.10 3.45 3.45 3.45 3.45 2.38 2.38 2.382
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $-0.41 $-0.30 $-0.24 $-0.00 $-0.88 $-1.02 $-1.20 $-1.53 $-0.93 $-1.01 $-1.09 $-1.07 $-1.48 $-1.78 $-1.97 $-1.70 $0.05 $0.63 $1.45 $2.06 $2.06
Book Value/Share $-2.28 $-1.89 $3.60 $3.68 $3.69 $3.69 $2.18 $2.18 $2.22 $2.16 $1.63 $1.48 $1.48 $1.29 $0.74 $0.73 $0.70 $0.71 $2.70 $2.57 $3.52
Tangible Book/Share $-2.28 $-1.89 $3.60 $3.68 $3.69 $3.69 $2.18 $2.18 $2.22 $2.16 $-0.32 $-0.29 $-0.29 $-0.25 $-0.63 $-0.63 $-0.60 $-0.61 $2.51 $2.38 $2.38
Revenue/Share $0.97 $0.81 $0.81 $0.59 $0.28 $0.31 $0.30 $0.28 $0.50 $0.49 $0.73 $0.67 $0.57 $0.52 $0.44 $0.75 $1.10 $1.51 $1.86 $2.03 $2.09
FCF/Share $0.40 $0.29 $0.29 $0.27 $-0.33 $-0.44 $-0.55 $-0.56 $-0.71 $-0.64 $-0.89 $-1.10 $-1.34 $-1.46 $-1.30 $-1.14 $-0.83 $-0.43 $-0.04 $0.20 $0.21
OCF/Share $0.41 $0.29 $0.30 $0.28 $-0.33 $-0.44 $-0.54 $-0.56 $-0.70 $-0.63 $-0.88 $-1.09 $-1.34 $-1.46 $-1.30 $-1.14 $-0.82 $-0.42 $-0.03 $0.21 $0.22
Cash/Share $0.14 $0.12 $3.18 $3.26 $3.26 $3.26 $2.40 $2.40 $2.44 $2.39 $1.79 $1.62 $1.62 $1.42 $1.29 $1.28 $1.23 $1.24 $3.34 $3.17 $1.64
EBITDA/Share $-0.27 $-0.24 $-0.22 $0.01 $-0.89 $-1.02 $-1.19 $-1.52 $-0.89 $-1.08 $-1.13 $-1.06 $-1.38 $-1.54 $-1.42 $-1.11 $0.65 $1.20 $1.72 $1.76 $1.76
Debt/Share $2.42 $2.00 $0.05 $0.05 $0.05 $0.05 $0.54 $0.54 $0.55 $0.54 $1.15 $1.05 $1.04 $0.92 $1.12 $1.11 $1.07 $1.08 $1.10 $1.05 $1.05
Net Debt/Share $2.27 $1.88 $-3.13 $-3.21 $-3.21 $-3.21 $-1.86 $-1.86 $-1.89 $-1.85 $-0.63 $-0.57 $-0.57 $-0.50 $-0.17 $-0.17 $-0.16 $-0.16 $-2.23 $-2.12 $-2.12
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score — — — — — — — — — — — — — — — — — — — — 2.917
Altman Z-Prime snapshot only 6.373
Piotroski F-Score 5 5 5 6 5 5 2 2 3 2 4 3 3 3 4 5 6 6 6 7 7
Beneish M-Score -12.01 -11.00 -2.33 -2.18 -1.01 -2.23 1.11 1.08 2.28 1.10 1.90 9.56 1.97 -0.66 -3.87 -0.04 2.10 3.48 0.29 0.22 0.222
Ohlson O-Score snapshot only -9.132
ROIC (Greenblatt) snapshot only 55.78%
Net-Net WC snapshot only $1.54
EVA snapshot only $-48079118.11
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only AA-
Credit Score 20.00 20.00 71.28 60.40 63.30 63.72 31.92 31.54 31.37 31.65 21.14 21.39 21.10 21.21 26.42 26.12 40.86 54.09 78.55 84.18 84.184
Credit Grade snapshot only 4
Credit Trend snapshot only 58.064
Implied Spread (bps) snapshot only 100.000
Industry Credit Rank snapshot only 87
Sector Credit Rank snapshot only 79

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms